EGIS Pharmaceuticals Public Limited Company is one of the leading pharmaceutical companies in Central Europe, realising in the business year of 2008/2009 net sales 106 billion HUF. (appr. 600 mill USD) This result was 11% higher than the net sales in the previous year. 69% of our sales revenue comes from our export activity. We export our finished products first of all to the Eastern regions like Russia, Central- and Eastern-European countries, and the CIS countries. The sales to these regions make up the 80 % of the total export.Our production system meets the international GMP principles, the regulations of the Hungarian National Institute of Pharmacy and those issued by the American FDA, the most stringent authority in the field of licensing drugs.Our research work focuses mainly on drugs effective on cardiovascular diseases, disorders of the central nervous system, the respiratory and digestive. EGIS PLC is ranked first on the basis of the number of packages sold in the Hungarian market, and is placed fifth concerning our sales revenue.

Core Sales Territory: All of Europe

Core Operation: Sales and Marketing, Finished Dose Manufacture, API Manufacture

Number of molecules sold: 90

Company's rating: